The Light at the end of the Tunnel

INO.com

The below offer is brought to you by Legend Research

Trading Forex,

There's a lot of uncertainty right now around Coronavirus. Will the vaccine work on new strains? What will the long-term economic fallout be?

However, there's one thing I know for a fact - your desire for wealth has never and will never fade; that my friend is a certainty, dreams never die.

Last year I was on the right side of 15 FDA approvals and 12 takeovers in the bio-tech sector picking up massive percentage gains. So far this year, both CRSP and EDIT recommendations have started 2021 off right for our clients.

My soon to be new valued client, put your mind and heart at ease. There is one certainty on Wall Street when you position yourself into a stock well before the masses have any idea of an FDA approval; you can rest assured no matter what's happening in the world this stock has the best chance to work and even possibly will make a huge run.

I have consistently put investors into some of the best situations due to my ability and foresight to position themselves long before the news hits the street. Not only do you stand the chance of possibly making more money than you've ever made in your life, you can become legendary.

So here it is my gift to you absolutely FREE, the 2020 Legend Research legendary FDA approval of a lifetime; a trade so powerful it can only be considered the single most profitable trade you will ever place in your account. Click this link now and I will hand-deliver you this life-changing opportunity for FREE.

Sincerely,
Legend Research

To accept this special invitation, click here.

 
Indexes Snapshot
Symbol Last Change %
Dow Jones Industrial Average 30814.26 -177.26 -0.65%
NASDAQ Composite 12998.50 -114.14 -1.02%
S&P 500 3768.25 -27.29 -0.81%
SPDR S&P 500 375.70 -2.76 -0.82%
iShares Russell 2000 ETF 210.7350 -3.2050 -2.00%
U.S. STOCK INDEXES

The Dow closed lower on Friday but were off session lows after President-elect Joe Biden announced a $1.9 trillion COVID-19 relief plan late-Thursday. Data also showed December retail sales fell for a third month in a row. A number of analysts are skeptical about the chances of Biden's fiscal package passing Congress intact. The high-range close sets the stage for a steady to lower opening when Tuesday's night session begins trading. Stochastics and the RSI are overbought and are turning neutral to bearish signaling that a short-term top might be in or is near. Closes below last-Monday's low crossing at 29,881.82 would confirm that a short-term top has been posted. If the Dow extends this month's rally into uncharted territory, upside targets will be hard to project. First resistance is Thursday's high crossing at 31,223.78. Second resistance is unknown. First support is the 20-day moving average crossing at 30,569.74. Second support is the 50-day moving average crossing at 29,998.81.

The March NASDAQ 100 closed lower on Friday. The mid-range close sets the stage for a steady to lower opening when Tuesday's night session begins trading. Stochastics and the RSI are neutral to bearish hinting that a short-term top might be in or is near. Closes below last-Monday's low crossing at 12,491.25 are needed to confirm that a short-term top has been posted. If March extends the rally off September's low into uncharted territory, upside targets will be hard to project. First resistance is last-Friday's high crossing at 13,065.75. Second resistance is unknown. First support is last-Monday's low crossing at 12,491.25. Second support is the 50-day moving average crossing at 12,439.37.

The March S&P 500 closed lower on Friday. The low-range close sets the stage for a steady to lower opening when Tuesday's night session begins trading. Stochastics and the RSI are overbought but remain neutral to bullish signaling that sideways to higher prices are possible near-term. If March extends the rally off November's low into uncharted territory, upside targets will be hard to project. Multiple closes below the reaction low crossing at 3636.00 would confirm that a short-term top has been posted. First resistance is last-Friday's high crossing at 3824.40. Second resistance is unknown. First support is the 20-day moving average crossing at 3735.76. Second support is the 50-day moving average crossing at 3649.60.



Thank you!

Thank you for subscribing to Market Commentary from INO.com.

You can modify your email preferences or unsubscribe here.

INO.com, Inc. | 228 Park Avenue South, Suite 320 | New York, New York 10003

U.S. Government Required Disclaimer - Commodity Futures Trading Commission Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results

These results are based on simulated or hypothetical performance results that have certain inherent limitations. Unlike the results shown in an actual performance record, these results do not represent actual trading. Also, because these trades have not actually been executed, these results may have under-or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity. Simulated or hypothetical trading programs in general are also subject to the fact that they are designed with the benefit of hindsight. No representation is being made that any account will or is likely to achieve profits or losses similar to these being shown.

All trades, patterns, charts, systems, etc., discussed in this message and the product materials are for illustrative purposes only and not to be construed as specific advisory recommendations. All ideas and material presented are entirely those of the author and do not necessarily reflect those of the publisher or INO.com. No system or methodology has ever been developed that can guarantee profits or ensure freedom from losses. No representation or implication is being made that using the methodology or system will generate profits or ensure freedom from losses. The testimonials and examples used herein are exceptional results, which do not apply to the average member, and are not intended to represent or guarantee that anyone will achieve the same or similar results. Each individual's success depends on his or her background, dedication, desire, and motivation.

No comments:

Post a Comment